GlassScriptPhysician profile
Jeffrey C Pauloski
NPI 1619967858
$1,482.00
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $184 · 2021: $354 · 2022: $475.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.57 | 2019-2022 | |
| Hologic Sales and Service, LLC | $157.93 | 2019-2022 | |
| Pfizer INC. | $126.64 | 2019-2022 | |
| Coopersurgical, INC. | $123.73 | 2019-2022 | |
| Radius Health, INC. | $107.56 | 2019-2022 | |
| Therapeuticsmd, INC. | $86.37 | 2020-2022 | |
| Avion Pharmaceuticals | $84.80 | 2019-2021 | |
| Lupin INC. | $71.05 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.16 | 2019-2022 | |
| Myovant Sciences INC. | $51.87 | 2022 | |
| Mayne Pharma Commercial LLC | $47.60 | 2021-2022 | |
| Medtronic, INC. | $43.41 | 2022 | |
| Duchesnay USA Incorporated | $42.65 | 2019 | |
| Agile Therapeutics, INC. | $41.70 | 2021-2022 | |
| Organon LLC | $35.94 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $35.18 | 2022 | |
| Merck Sharp & Dohme LLC | $28.37 | 2019 | |
| Scynexis, INC. | $25.13 | 2022 | |
| Hologic INC | $17.50 | 2021 | |
| Medicem INC. | $17.42 | 2021 | |
| Smith+Nephew, INC. | $17.21 | 2022 | |
| Medtronic USA, INC. | $17.04 | 2019 | |
| Evofem Biosciences, INC. | $16.91 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.24 | 2019 | |
| Exeltis, USA INC. | $15.03 | 2021 | |
| Avanos Medical | $14.99 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pauloski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.